-
2023-510380-34-00
4
2024-12-10
Diffuse cutaneous systemic sclerosis (dcSSc)
-
2023-506003-26-00
1
2024-11-27
Relapsed and/or Refractory Multiple Myeloma
-
2024-511465-11-00
5
2024-11-20
Spontaneous lobar ICH
-
2024-512835-53-00
4
2024-11-20
Diffuse Large B-Cell Lymphoma
-
2023-505232-36-00
5
2024-11-15
Essential thrombocythemia
-
2024-513098-31-00
4
2024-11-14
Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma
-
2024-516011-24-01
4
2024-11-13
Cytomegalovirus infection in allogeneic stem cell transplant recipient
-
2023-504724-25-00
5
2024-10-16
Primary Myelofibrosis
-
2023-510136-36-00
1
2024-09-27
Advanced Non-Hodgkin’s Lymphoma
-
2023-507803-76-00
10
2024-09-26
Peripheral T-Cell Lymphoma
-
2022-500800-24-00
4
2024-09-19
Multiple Myeloma
-
2023-504647-14-00
4
2024-09-02
Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)
-
2023-503550-13-00
7
2024-08-08
Large Granular Lymphocytic Leukemia or Cytotoxic Lymphomas
-
2022-502135-19-00
4
2024-07-18
Calcific Aortic Valve Stenosis
-
2024-511309-47-00
4
2024-07-17
moderate thrombocytopenia
-
2024-514880-25-00
5
2024-06-27
Patients with cardiovascular alterations induced by cirrhosis, diabete
-
2023-508590-89-00
7
2024-06-25
Multiple Myeloma
-
2022-501697-19-01
5
2024-06-18
Small Lymphocytic Lymphoma (SLL) / Untreated Chronic Lymphocytic Leuke
-
2023-505436-35-00
5
2024-06-03
Untreated FLIPI 2-5 Follicular Lymphoma
-
2023-508613-17-00
5
2024-05-29
Neoplasms, Head and Neck
-
2023-507871-23-00
5
2024-05-27
Relapsed/Refractory Multiple Myeloma
-
2023-505024-62-01
4
2024-05-16
Oligometastatic patients with castration-resistant
prostate cancer
-
2023-505621-13-00
4
2024-05-14
Richter´syndrome
-
2024-513601-31-00
4
2024-05-13
Acute lymphoid leukemia